Industry

Ad hoc announcement pursuant to Art. 53 LR ZUG, Switzerland–(BUSINESS WIRE)–Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year 2025. Record net sales of 5,207 million USD, surpassing 5 billion USD in a year for the first time and representing 17.7% year-on-year growth on a constant … [Read more…]

NEW YORK–(BUSINESS WIRE)–Allosteric Bioscience, Inc. is utilizing Genetics, Genomics, Systems Biology, Quantum Computing, Advanced Proprietary AI and Proprietary Molecular Technologies for understanding and controlling the Molecular Mechanism of Aging and Longevity with the goal of optimizing the aging process and extending longevity. Aging factors that are being targeted are Lamin A which is critical for … [Read more…]

–Results show that targeting the underlying cause of Dravet syndrome with zorevunersen may improve outcomes for people with this rare, devastating genetic neurodevelopmental disease– –Data support ongoing global Phase 3 EMPEROR study– BEDFORD, Mass. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential … [Read more…]

– U.S. FDA places FREEDOM2 trial on partial clinical hold related to preclinical pharmacology and toxicology – – Received regulatory clearance to initiate FREEDOM2 in South Korea, Australia, and New Zealand and dosing of the 10 mg/kg cohort continues in the UK and Canada – – PepGen reiterates guidance for reporting data from the FREEDOM2 … [Read more…]

NEW ORLEANS–(BUSINESS WIRE)–A retrospective study by Hospital for Special Surgery (HSS) investigators found that infection rates at a high-volume academic orthopedic center following total knee arthroplasty (TKA) are uniformly low regardless of individual surgeon volume. These findings challenge the long-held belief that a surgeon’s experience, not the institution’s, drives safety outcomes. The research team shared … [Read more…]

The new suite brings advanced treatment options to pediatric patients with various types of strokes, including blood vessel malformations causing bleeding in the brain, as well as blood clots MINNEAPOLIS–(BUSINESS WIRE)–Children’s Minnesota is pleased to announce a $2.5 million, state-of-the-art biplane neuroangiography suite—the region’s only facility dedicated to pediatric neurointerventional procedures. This advanced imaging technology … [Read more…]

WALTHAM, Mass.–(BUSINESS WIRE)–Vicarious Surgical Inc. (NYSE: RBOT) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced that on March 3, 2026, it received a notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the NYSE has commenced the process of delisting the Company’s Class … [Read more…]

Provides structured US market access for EvoLiver FDA-designated liver cancer surveillance test across health systems, payors and clinical stakeholders CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve chronic disease outcomes for at-risk patients, today announced it has been selected to join the Association of … [Read more…]

COLLEGE PARK, Ga.–(BUSINESS WIRE)–Anthem Blue Cross Blue Shield, in partnership with iHeartMedia and national nonprofit Impact Fitness Foundation, recently celebrated the unveiling of a newly upgraded weight room they provided at Benjamin Banneker High School. The project expands Anthem’s commitment to whole health in the College Park community and supports long-term student wellness by investing … [Read more…]

LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued a Shareholder Letter on Tuesday, March 3 after the market close. STAAR’s results release can be found here: https://investors.staar.com/news-and-events/press-releases. Fellow Shareholders, This past month marked an … [Read more…]